home / stock / zsan / zsan news

ZSAN News and Press, Zosano Pharma Corporation

Stock Information
Company Name: Zosano Pharma Corporation
Stock Symbol: ZSAN
Market: NASDAQ
Website: zosanopharma.com
Menu
ZSAN ZSAN Quote ZSAN Short ZSAN News ZSAN Articles ZSAN Message Board
Get ZSAN Alerts

News, Short Squeeze, Breakout and More Instantly...
ZSAN - ADAP, SLDP and ZSAN among mid-day movers

Gainers: Turning Point Therapeutics (TPTX) +117%. Energy Focus (EFOI) +40%. Galecto (GLTO) +25%. Adaptimmune (ADAP) +22%. Amylyx Pharmaceuticals (AMLX) +22%. AudioEye (AEYE) +20%. Sprague Resources LP (SRLP) +20%. Global Cord Blood (CO) +18%. GreenBox (GBOX) +17%. Kopin (KOPN) +15%. Losers: N...
ZSAN - Immix, Bright Green top healthcare gainers; while Zosano, Immunic lead losers' pack

Gainers: Immix Biopharma (IMMX) +37%. Bright Green (BGXX) +29%. Repare Therapeutics (RPTX) +29%. Yumanity Therapeutics (YMTX) +24%. PDS Biotechnology (PDSB) +15%. Losers: Zosano Pharma (ZSAN) -48%. Immunic (IMUX) -41%. Aeglea BioTherapeutics (AGLE) -40%...

ZSAN - Zosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%

Zosano Pharma (NASDAQ:ZSAN) has filed a petition for relief under Chapter 11 bankruptcy protection. Shares are down 46% in premarket trading Zosano (ZSAN) is continuing to operate as a "debtor-in-possession" under the jurisdiction of a bankruptcy court. The company noted its intenti...

ZSAN - Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11

FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary petition for relief under chapter 11 of title 11 (“Chapter 11”) of the United ...
ZSAN - Five Narrow Lane Made a Big Bet on Vinco Ventures (BBIG) Stock

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: vincoventures.com Shares of Vinco Ventures rose as high as $2.57 today after Five Narrow Lane disclosed through a 13G form that it had taken a 9.67% stake in BBIG stock. A 13G form implies passive ownership. M...

ZSAN - Zosano Pharma  GAAP EPS of -$7.86 misses by $7.81, revenue of $0.14M beats by $0.04M

Zosano Pharma  press release (NASDAQ:ZSAN): Q1 GAAP EPS of -$7.86 misses by $7.81. Revenue of $0.14M (-46.2% Y/Y) beats by $0.04M. For further details see: Zosano Pharma  GAAP EPS of -$7.86 misses by $7.81, revenue of $0.14M beats by $0.04M

ZSAN - Zosano Pharma Reports First Quarter 2022 Financial Results

FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results a...
ZSAN - Silk Road Medical, Clene top healthcare gainers; Global Cord Blood, Zosano lead losers' pack

Gainers: Silk Road Medical (SILK) +12%. Clene (CLNN) +6%. BioCardia (BCDA) +2%. Veru (VERU) +2%. ERYTECH Pharma (ERYP) +1%. Losers: Global Cord Blood (CO) -28%. Zosano Pharma (ZSAN) -21%. Vaxxinity (VAXX) -17%. HUTCHMED (China) (HCM)...

ZSAN - Zosano Pharma suspends program for migraine treatment M207

Zosano Pharma (NASDAQ:ZSAN) on Friday said it had suspended its program for its migraine treatment M207 in order to preserve its capital and cash resources. ZSAN stock -1.6% to $1.90 in aftermarket trading. The U.S. Food and Drug Administration earlier in April had given the company a 12-mont...

ZSAN - Zosano Pharma Provides Corporate Update

FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update. On April 14, 2022, the Food and Drug Administration granted Zosano a twelve-month extension to April 20, 202...
Next 10